A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease

Journal of the American College of Cardiology

Volumn 63, Issue 3, 2014, Pages 233-239

  Ford, Isobel ^a   Scott, Neil W ^a   Herd, Vera ^a,b   Mitchell, Louise R ^a   Williams, David J P ^b,c   Brittenden, Julie ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c Royal College   (Ireland)

Author keywords

clopidogrel; platelets; rebound

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; FIBRINOGEN; PADGEM PROTEIN; PLACEBO;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REBOUND; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANALYTIC METHOD; BLOOD SAMPLING; CELL STIMULATION; DISEASE ACTIVITY; DRUG WITHDRAWAL; LIGHT TRANSMISSION AGGREGOMETRY; OUTCOME ASSESSMENT; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; TREATMENT DURATION;

ADENOSINE DIPHOSPHATE; ADP; CAD; CLOPIDOGREL; CORONARY ARTERY DISEASE; PAD; PERIPHERAL ARTERIAL DISEASE; PLATELETS; REBOUND;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84892707651     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.018     Document Type: Article

References (28)

1. R.F. Storey Biology and pharmacology of the platelet P2Y12 receptor Curr Pharm Des 12 2006 1255 1259
2. T.W. Rooke, A.T. Hirsch, and S. Misra et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease J Am Coll Cardiol 58 2011 2020 2045
3. P.G. Steg, S.K. James, and D. Atar et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
4. C.W. Hamm, J.P. Bassand, and S. Agewall et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 32 2011 2999 3054
5. H. Jneid, J.L. Anderson, and R.S. Wright et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction J Am Coll Cardiol 60 2012 645 681
6. P.M. Ho, E.D. Peterson, and L. Wang et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome JAMA 299 2008 532 539
7. A.T.L. Ong, E.P. McFadden, E. Regar, P.P. de Jaegere, R.T. van Domburg, and P.W. Serruys Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2005 2088 2092
8. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
9. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease Diabetes 55 2006 780 784
10. M. Lordkipanidzé, J.G. Diodati, and C. Pharand Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence Pharmacol Therapeut 123 2009 178 186
11. P. Diehl, C. Halscheid, C. Olivier, T. Helbing, C. Bode, and M. Moser Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation Clin Res Cardiol 100 2011 765 771
12. D. Mylotte, A.J. Peace, and A.T. Tedesco et al. Clopidogrel discontinuation and platelet reactivity following coronary stenting J Thromb Haemost 9 2011 24 32
13. D. Sibbing, J. Stegherr, and S. Braun et al. A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment J Am Coll Cardiol 55 2010 558 565
14. C. Main, S. Palmer, and S. Griffin et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment elevation acute coronary syndromes: a systematic review and economic evaluation Health Technol Assess 8 2004:iii-iv, xv-xvi, 1-141
15. M.A. Gaglia, and R. Waksman Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes Eur Heart J 32 2011 2358 2364
16. Electronic Medicines Compendium summary of product characteristics. Plavix 75 mg. Available at: http://www.medicines.org.uk/emc/medicine/24207/spc/ plavix+75mg+tablets#furtherinfo. Accessed August 22, 2013.
17. N.W. Scott, G.C. McPherson, C.R. Ramsay, and M.K. Campbell The method of minimization for allocation to clinical trials: a review Control Clin Trial 23 2002 662 674
18. K. Cassar, I. Ford, M. Greaves, P. Bachoo, and J. Brittenden Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty Br J Surg 92 2005 159 165
19. N.J. Breet, J.W. VanWerkum, H.J. Bouman, J.C. Kelder, J.M. Ten Berg, and C.M. Hackeng High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events J Thromb Haemost 8 2010 2140 2148
20. K. Cassar, P. Bachoo, I. Ford, M. Greaves, and J. Brittenden Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease Eur J Vasc Endovasc Surg 29 2005 171 176
21. S. Rabe-Hesketh, and A. Skrondal Multilevel and longitudinal modeling using Stata 2005 Stata Press College Station, TX
22. P.A. Gurbel, K.P. Bliden, M.J. Antonino, M. Gesheff, Y.-H. Jeong, and U.S. Tantry Is there a rebound after cessation of antiplatelet therapy? First comparison of irreversible vs. reversible P2Y12 receptor blocker [abstr] J Thromb Haemost 2011 Suppl 2:O-MO-119
23. D.J. Angiolillo, J.J. Badimon, and J.F. Saucedo et al. A pharmacodynamic comparison of prasugrel vs high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease Eur Heart J 32 2011 838 846
24. A.L. Frelinger, M.R. Barnard, M.L. Fox, and A.D. Michelson The Platelet Activity After Clopidogrel Termination (PACT) Study Circ Cardiovasc Interv 3 2010 442 449
25. N. Sambu, H. Dent, and N. Englyst et al. Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study Heart 97 2011 1661 1667
26. N. Djukanovic, Z. Todorovic, and S. Obradovic et al. Abrupt cessation of one-year clopidogrel treatment is not associated with thrombotic events J Pharmacol Sci 117 2011 12 18
27. M. Lordkipanidzé, and P. Harrison Beware of being caught on the rebound J Thromb Haemost 9 2011 21 23
28. G. Lemesle, R. Torguson, and L. Bonello et al. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents EuroIntervention 6 2011 1053 1059